64 related articles for article (PubMed ID: 11147468)
1. Resolution of syndrome X after eradication of virulent CagA-positive Helicobacter pylori.
Nocente R; Gentiloni N; Cremonini F; Giorgi A; Serricchio M; Santoliquido A; Gasbarrini G; Gasbarrini A
South Med J; 2000 Oct; 93(10):1022-3. PubMed ID: 11147468
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
3. Possible pathogenetic role of Helicobacter pylori infection in cardiac syndrome X.
Celik T; Iyisoy A; Yuksel UC
Int J Cardiol; 2010 Jul; 142(2):193-4. PubMed ID: 19070380
[TBL] [Abstract][Full Text] [Related]
4. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.
Kodama M; Kitadai Y; Ito M; Kai H; Masuda H; Tanaka S; Yoshihara M; Fujimura K; Chayama K
Helicobacter; 2007 Feb; 12(1):36-42. PubMed ID: 17241299
[TBL] [Abstract][Full Text] [Related]
5. Possible role of Helicobacter pylori infection via microvascular dysfunction in cardiac syndrome X.
Rasmi Y; Raeisi S
Cardiol J; 2009; 16(6):585-7. PubMed ID: 19950100
[TBL] [Abstract][Full Text] [Related]
6. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
Yang G; Hu F; Jia J
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
[TBL] [Abstract][Full Text] [Related]
7. [CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study].
Bommelaer G; Bruley Des Varannes S; Fléjou JF; Matysiak T; Poynard T; Richard A; Slama A; Mégraud F;
Gastroenterol Clin Biol; 2001 Dec; 25(12):1084-9. PubMed ID: 11910990
[TBL] [Abstract][Full Text] [Related]
8. Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.
Saruç M; Demir MA; Küçükmetin N; Kandiloglu AR; Akarca US; Yüceyar H
Hepatogastroenterology; 2002; 49(45):878-81. PubMed ID: 12064012
[TBL] [Abstract][Full Text] [Related]
9. Resolution of gastrointestinal protein loss after Helicobacter pylori eradication in a patient with hypertrophic lymphocytic gastritis.
Madisch A; Aust D; Morgner A; Grossmann D; Schmelz R; Kropp J; Ehninger G; Baretton G; Miehlke S
Helicobacter; 2004 Dec; 9(6):629-31. PubMed ID: 15610076
[TBL] [Abstract][Full Text] [Related]
10. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
Suzuki T; Matsushima M; Masui A; Watanabe K; Takagi A; Ogawa Y; Shirai T; Mine T
Am J Gastroenterol; 2005 Jun; 100(6):1265-70. PubMed ID: 15929755
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.
Ando T; Tsuzuki T; Mizuno T; Minami M; Ina K; Kusugami K; Takamatsu J; Adachi K; El-Omar E; Ohta M; Goto H
Helicobacter; 2004 Oct; 9(5):443-52. PubMed ID: 15361084
[TBL] [Abstract][Full Text] [Related]
13. Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases?
Jovanovic IR; Milosavjevic TN; Jankovic GP; Micev MM; Dugalic PD; Saranovic D; Ugljesic MM; Popovic DV; Bulajic MM
Med Sci Monit; 2001; 7(1):137-41. PubMed ID: 11208510
[TBL] [Abstract][Full Text] [Related]
14. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction.
Ackermark P; Kuipers EJ; Wolf C; Breumelhof R; Seldenrijk CA; Timmer R; Segeren KC; Kusters JG; Smout AJ
Am J Gastroenterol; 2003 Aug; 98(8):1719-24. PubMed ID: 12907324
[TBL] [Abstract][Full Text] [Related]
15. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
Masaoka T; Suzuki H; Imaeda H; Hosoda H; Ohara T; Morishita T; Ishii H; Kangawa K; Hibi T
Hepatogastroenterology; 2005; 52(61):1-4. PubMed ID: 15782980
[TBL] [Abstract][Full Text] [Related]
16. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
[TBL] [Abstract][Full Text] [Related]
17. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Helicobacter pylori infection, endoscopic gastric findings and dyspeptic symptoms among a young Japanese population born in the 1970s.
Shimatani T; Inoue M; Iwamoto K; Hyogo H; Yokozaki M; Saeki T; Tazuma S; Horikawa Y
J Gastroenterol Hepatol; 2005 Sep; 20(9):1352-7. PubMed ID: 16105120
[TBL] [Abstract][Full Text] [Related]
19. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis.
Teh M; Tan KB; Seet BL; Yeoh KG
Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741
[TBL] [Abstract][Full Text] [Related]
20. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
